Tofacitinib Benefits Sustained for Two Years in Patients With RA

MONDAY, Feb. 4, 2019 -- The clinical benefits of tofacitinib in combination with methotrexate are sustained over two years among patients with rheumatoid arthritis (RA), according to a study published online Jan. 22 in Arthritis&...

Source: Drugs.com - Pharma News - February 4, 2019 Category: Pharmaceuticals Source Type: news